Concepedia

Author

Elena Wolff‐Holz

Paul Ehrlich InstitutORCID

Also Known As

E. Wolff-Holz, Elena Wolff-Holz, Elena Wolff‐Holz

24

Publications

907

Citations

10

H-Index

42

Concepts

All Affiliations

Paul Ehrlich InstitutFinnish Medicines Agency FimeaFederal Institute for Drugs and Medical DevicesStichting Apotheek der Haarlemse ZiekenhuizenHealth and Safety Authority
EW

About

Elena Wolff‐Holz is an author at Paul Ehrlich Institut specializing in medicine, pharmacology, and biotechnology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

142

2

Engineering

2

2

253

3

Public Health

2

2

60

4

Biostatistics

2

2

60

5

Epidemiology

1

1

34

Elena Wolff‐Holz

×

7

Publications

701

Citations

7

H-Index

YearCitations

Biosimilars: the science of extrapolation

Martina Weise, Pekka Kurki, Elena Wolff‐Holz,

Blood

2014

292

Interchangeability of Biosimilars: A European Perspective

Pekka Kurki, Leon van Aerts, Elena Wolff‐Holz,

BioDrugs

2017

171

Equivalence of complex drug products: advances in and challenges for current regulatory frameworks

L. Hussaarts, Stefan Mühlebach, Vinod P. Shah,

Annals of the New York Academy of Sciences

2017

82

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective

Pekka Kurki, Sean Barry, Ingrid Bourges,

Drugs

2021

81

Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice

Niels S. Vermeer, Thijs J. Giezen, Sofia Zastavnik,

Clinical Pharmacology & Therapeutics

2018

34

A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies

Elena Guillén, Niklas Ekman, Sean Barry,

Clinical Pharmacology & Therapeutics

2022

26

Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016

Vito Annese, C. Avendaño, Ferdinand C. Breedveld,

Generics and Biosimilars Initiative Journal

2016

15

Page 1